Series E - NGM Biopharmaceuticals - Mar 25, 2015 Funding Round Profile - Cointime

Bitcoin $97,637.31 +0.13%
Ethereum $3,278.49 -2.20%
BNB $620.20 -0.48%
Optimism $2.15 +4.67%
Arbitrum $0.79 -1.10%
Solana $254.83 +3.32%
Polygon $0.45 +0.22%
Cosmos $6.86 +6.65%
Avalanche $37.83 +5.54%

Bitcoin $97,637.31 +0.13%
Ethereum $3,278.49 -2.20%
BNB $620.20 -0.48%
Optimism $2.15 +4.67%
Arbitrum $0.79 -1.10%
Solana $254.83 +3.32%
Polygon $0.45 +0.22%
Cosmos $6.86 +6.65%
Avalanche $37.83 +5.54%

NGM Biopharmaceuticals

company

Funding Round

Series E

Money Raised

$ 105.99M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	Yes	-	Detail